News of Note—Fresenius recalls 163 lots of sodium chloride

Cancer in newspaper clipping
(Pixabay)

> Fresenius Kabi USA is voluntarily recalling 163 lots of Sodium Chloride Injection, because the labels incorrectly state that the stoppers do not contain latex. Release

> Ian Hudson, M.D., chief executive of the Medicines and Healthcare Products Regulatory Agency, has announced he will retire from MHRA in September 2019. Pharmafield article

> CDMO Dalton Pharma Services has a drug development and manufacturing services agreement with stem cell biotech ExCellThera for formulation and fill/finish services at its plant in Toronto, Canada. Release

Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> Oxford BioMedica will invest £4 million to build digital and robotics capabilities to increase capacity, reduce the cost of manufacturing and reduce waste in its cell manufacturing. Release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.